Related Experiment Video
Updated: Sep 18, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Propofol Total Intravenous Anesthesia for Pediatric Proton Radiotherapy and Its Effect on Patient Outcomes
Pascal Owusu-Agyemang1,2, Julie Mani1, Techecia Idowu1
1Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Insights
Iterative anesthesia with propofol-TIVA during pediatric proton beam therapy (PBT) did not impact overall survival. However, it was linked to a higher risk of unplanned hospital visits within 30 days of treatment initiation.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Anesthesiology
Background:
- Patient motion complicates radiotherapy delivery, especially in pediatric proton beam therapy (PBT).
- Children may require up to 30 general anesthesia sessions over 6-8 weeks for PBT.
- The long-term effects of repeated anesthetic exposures in pediatric PBT are not well understood.
Purpose of the Study:
- To evaluate the impact of propofol-based total intravenous anesthesia (TIVA) on overall survival in pediatric PBT.
- To determine the association between propofol-TIVA and unplanned hospital admissions or emergency room visits within 30 days of PBT initiation.
Main Methods:
- Retrospective analysis of pediatric patients (≤19 years) undergoing PBT for central nervous system disease.
- Comparison of outcomes between patients receiving PBT with propofol-TIVA versus those without anesthesia.
- Statistical analysis included Log-rank tests, Cox proportional hazards models, propensity score matching, and E-value analyses.
Main Results:
- Overall survival rates at 1, 2, and 3 years were similar between groups receiving PBT with propofol-TIVA and those without anesthesia (p=0.558).
- Patients receiving propofol-TIVA were younger and had higher rates of treatment interruptions, prior chemotherapy, concurrent chemotherapy, and unplanned admissions/ER visits (p<0.001).
- Multivariable analysis revealed propofol-TIVA was associated with significantly increased odds of unplanned admission/ER visit (OR, 38.311-42.012; p<0.001).
Conclusions:
- Propofol-TIVA during pediatric PBT is not associated with differences in overall survival.
- Pediatric PBT with propofol-TIVA is linked to an elevated risk of unplanned hospitalizations or ER visits within 30 days of treatment commencement.
Abstract:
Background: Patient motion poses significant challenges for the accurate delivery of radiotherapy. In children undergoing proton beam therapy (PBT), up to 30 treatments under general anesthesia may be required over a period of 6 to 8 weeks. To date, the impact of this many iterative anesthetic exposures on patient outcomes remains unclear. Objective: The primary objective of this study was to assess the impact of iterative anesthesia with propofol-based total intravenous anesthesia (propofol-TIVA) on overall survival. The secondary objective was to assess the association between propofol-TIVA and the occurrence of an unplanned admission or emergency room visit within 30 days of treatment start. Methods: This was a retrospective study of children (≤19 years) who had undergone PBT (with or without anesthesia) for central nervous system disease. The Log-rank test and Cox proportional hazards models were used for analysis. Propensity score matching and E-value analyses were used to adjust for selection bias. Results: The average age of the 461 children included was 9.0 years (SD ± 4.9). The majority, 261/461 (56.6%), were male, and 267/461 (57.9%) had undergone PBT without anesthesia. The group who underwent PBT with propofol-TIVA were younger (4.7 years vs. 12.2 years, p < 0.001) and had higher proportions of patients with treatment interruptions (111/194 [57.2%] vs. 118/267 [44.2%], p = 0.006), chemotherapy history (64/194 [33.0%] vs. 18/267 [6.7%], p < 0.001), concurrent chemotherapy (37/194 [19.1%] vs. 27/267 [10.1%], p = 0.006), and unplanned admissions/emergency room visits (26/194 [13.4%] vs. 1/267 [0.4%], p < 0.001). Overall survival rates (propofol-TIVA vs. no anesthesia) at 1yr (94% vs. 96%), 2 years (88% vs. 90%), and 3 years (88% vs. 89%) were similar between patient groups (p = 0.558). In the multivariable analysis, PBT with propofol-TIVA was associated with increased odds of an unplanned admission/emergency room visit before (OR, 38.311; 95%CI, 5.139-285.580; p < 0.001) and after (OR, 42.012; 95% CI, 5.322-331.632; p < 0.001; E-value = 83.52) propensity score matching. Conclusions: In this retrospective study of children undergoing PBT for central nervous system disease, there was no association between anesthesia exposure with propofol-based total intravenous anesthesia and overall survival. However, PBT with propofol-based total intravenous anesthesia was associated with an increased risk of an unplanned admission/emergency room visit within 30 days of treatment start.
More Related Videos
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
Published on: June 8, 2021
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
Related Concept Videos
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Inhalational Anesthetics: Overview